On April 6, 2020, the Nevada Department of Health and Human Services ("Department") issued a notice (available here) granting an extension to the April 1 deadline for Essential Diabetes and Asthma Reports. According to the notice, the Department recognizes how the COVID-19 pandemic is affecting the ability of companies to meet deadlines. The deadline for submitting reports this year is April 16, 2020.
Previously, on March 24, 2020, the Department published an amended Diabetes and Asthma Essential Drug list. According to a notice from the Department, the 2020 Essential Drug List was revised to remove drugs that were not FDA-approved to treat diabetes or asthma. The amended list can be found here.
The Department has provided templates for reporting on its website. The standardized form includes all the fields required by law. Template headings should not be rearranged or changed. All values should be reported at the national level.
For more information, please visit Nevada's Price/Cost Disclosure section of the Transparency and Limitations Database.
If you are interested in receiving updates relevant to Life Sciences compliance, please contact us for two weeks of complimentary access to all Porzio Compliance Digest InfoCenters. Topics include US and International transparency, US Enforcement Action, HCP Authorities/Restrictions and Licensing Distribution: Trade and Sample.